Dr Tichenors with Extra Whitening and Tartar Control

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the prevention of dental cavities. It is intended for use in individuals at risk of developing dental caries.

Dosage and Administration

Adults and children aged two years and older should brush their teeth thoroughly, preferably after every meal or at least twice daily, or as directed by a dentist or physician. It is important to ensure that children under six years of age are instructed on proper brushing and rinsing techniques to minimize the risk of swallowing. Caregivers should supervise children as necessary until they are capable of brushing their teeth without assistance.

For children under two years of age, it is recommended to consult a dentist or physician for appropriate guidance on dental care.

Contraindications

Use is contraindicated in children under 6 years of age due to the potential risk of accidental ingestion. In the event of accidental ingestion exceeding the recommended amount for brushing, immediate professional assistance or contact with a Poison Control Center is advised.

Warnings and Precautions

In the event of accidental ingestion of an amount exceeding that typically used for brushing, it is imperative to seek emergency medical assistance immediately. Healthcare professionals should advise patients to contact a Poison Control Center without delay to ensure appropriate management of the situation.

While no specific warnings or general precautions are outlined, it is essential for healthcare providers to remain vigilant and monitor patients for any unusual symptoms or adverse reactions that may arise during the use of this product. Regular communication with patients regarding their usage and any concerns they may have is recommended to promote safe and effective use.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this medication. Serious side effects have been reported, necessitating careful monitoring and management.

Common adverse reactions observed in clinical trials include symptoms that may affect the quality of life of participants. These reactions were noted with varying frequencies, and while they are generally manageable, they should be communicated to patients to ensure they are prepared for potential occurrences.

In addition to the common adverse reactions, there are other important notes regarding additional adverse reactions that may arise during postmarketing surveillance. These reactions, while less frequent, underscore the importance of ongoing vigilance in monitoring patient responses to the medication.

Healthcare providers are encouraged to report any serious adverse reactions to ensure comprehensive safety data is collected and analyzed. This information is vital for understanding the full spectrum of potential risks associated with the medication.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Dr Tichenors with Extra Whitening and Tartar Control (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under six years of age should be kept out of reach of the product. For children two years of age and older, it is recommended to brush teeth thoroughly, preferably after every meal or at least twice a day, or as directed by a dentist or physician. Caregivers should instruct children under six on proper brushing and rinsing techniques to minimize swallowing, and supervision is advised until the child is capable of brushing without assistance. For children under two years of age, consultation with a dentist or physician is necessary prior to use. In the event of accidental ingestion of more than the amount used for brushing, immediate professional assistance or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while using this medication.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation associated with Dr. Tichenor's toothpaste. Therefore, lactating mothers may use this product without concern for adverse effects on breastfed infants.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments to ensure safety and efficacy. It is essential to assess creatinine clearance prior to initiating therapy in patients with reduced renal function. Additionally, these patients should be monitored closely throughout the treatment course. Periodic renal function tests are recommended to evaluate any changes and to guide ongoing management.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, altered mental status, or any unusual physiological responses.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. Healthcare professionals should also consider contacting a poison control center for additional guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, monitor for symptoms, and provide appropriate supportive care in the event of an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children under 6 years of age to prevent accidental ingestion. It is important to emphasize the potential risks associated with misuse. In the event that a patient accidentally swallows more than the amount recommended for brushing, they should be instructed to seek professional assistance or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing the risk of adverse effects.

Storage and Handling

The product is supplied in a tube format, with specific handling and storage requirements to ensure its integrity and efficacy. It should be stored at room temperature, away from extreme temperatures, and must be protected from freezing. To maintain the product's quality, the tube should be kept tightly closed when not in use. Additionally, it is recommended to discard the product after opening if it is not used within a specified time frame.

Additional Clinical Information

The medication is administered orally. Clinicians should counsel patients to keep the product out of reach of children under six years of age. In the event of accidental ingestion beyond the amount used for brushing, patients should seek professional assistance or contact a Poison Control Center immediately. It is important to instruct children under six on proper brushing and rinsing techniques to minimize swallowing, and to supervise their use until they are capable of using the product independently. For children under two years of age, consultation with a dentist or physician is advised.

Drug Information (PDF)

This file contains official product information for Dr Tichenors with Extra Whitening and Tartar Control, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)